| Record ID | harvard_bibliographic_metadata/ab.bib.14.20150123.full.mrc:165398933:1547 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.14.20150123.full.mrc:165398933:1547?format=raw |
LEADER: 01547nam a22004338i 4500
001 014121363-9
005 20140721160108.0
008 131029s2014 cau b 001 0 eng
010 $a 2013043146
020 $a9780123820303 (alk. paper)
035 0 $aocn861789148
040 $aDLC$beng$erda$cDLC
042 $apcc
050 00 $aRS403$b.S55 2014
060 00 $a2014 I-102
060 10 $aQV 744
082 00 $a615.1/9$223
100 1 $aSilverman, Richard B.,$eauthor.
245 14 $aThe organic chemistry of drug design and drug action.
250 $aThird edition /$bRichard B. Silverman, Mark W. Holladay.
264 1 $aSan Diego, CA :$bAcademic Press,$c2014
300 $axviii, 517 pages ;$billustrations (some color),$c29 cm.
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650 0 $aPharmaceutical chemistry.
650 0 $aBioorganic chemistry.
650 0 $aMolecular pharmacology.
650 0 $aDrugs$xDesign.
650 12 $aChemistry, Pharmaceutical.
650 22 $aChemistry, Organic.
650 22 $aDrug Design.
650 22 $aPharmacokinetics.
700 1 $aHolladay, Mark W.,$eauthor.
899 $a415_565171
988 $a20140721
906 $0DLC